Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06457997
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-06-06
Brief Title:
A Study of PHN-010 in Patients With Advanced Solid Tumors
Sponsor:
Pheon Therapeutics
Organization:
Pheon Therapeutics
Study Overview
Official Title:
First-in-Human Phase 1b Study of PHN-010 an Antibody Drug Conjugate in Patients With Advanced Solid Tumors
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This first-in-human study will evaluate safety tolerability anti-tumor activity immunogenicity pharmacokinetics and pharmacodynamics of PHN-010 a novel antibody-drug conjugate ADC in patients with advanced solid tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None